Navigation Links
Pharma's Most Innovative Companies, the 2017 Ranking
Date:2/27/2017

NEW YORK, February 27, 2017 /PRNewswire/ --

Now in its seventh year, the Pharmaceutical Innovation Index (PII) celebrates the pharmaceutical companies that are most successful at developing and commercialising innovation.

The Index can be summarised by the question: if you gave the same molecule to two different companies in early phase, which would make the best of it?

Based on systematic, objective analysis of each company's performance between 2011 and 2016, the 2017 ranking sees the return of some major pharma companies to the Top 10, with Bristol-Myers Squibb and Merck rising sharply, and continued strong performance from the mid-size, specialist players - Biogen tops the Index for the first time in its history. Johnson & Johnson, who had led the Index for 5 of the previous 6 years, continue to perform strongly, but were leapfrogged by outstanding performance from Biogen, AbbVie and Gilead.

Commenting on the index, IDEA Pharma's CEO, Mike Rea said: "The annual PII is the true measure of innovation in the pharma industry - meaningful medicines that deliver value to patients. The most eye-catching change in the R&D metrics for 2016 from the previous year was the fall in the number of new agents approved by the FDA: 22 for 2016 versus 45 in 2015. However, behind that headline was the companies getting the approvals: the outperformers of recent years, GlaxoSmithKline (GSK), Johnson & Johnson (J&J) and Novartis, did not get a novel drug approval in 2016. Neither did Amgen, AstraZeneca (AZ), Bayer and Bristol-Myers Squibb (BMS). In all, seven of the 13 historic big pharma companies, which received 14 approvals in 2015, came up empty-handed in 2016. The fact that innovation is being driven increasingly by smaller, possibly more agile companies, was highlighted by 14 of the 22 approvals coming from them. There are several signals there, for those who choose to listen. With 'innovation' such an overused term in the industry at the moment, the Pharmaceutical Innovation Index shows who is really delivering value to patients."

The PII looks subjective measures of 'innovation', and assesses companies based on a range of factors including speed to market, attrition rate across phases - in particular phase III, reimbursement rates, regulatory approvals, on-market performance and analyst rankings.

Change 2017 Companies from 2016 1 Biogen +5 2 AbbVie +3 3 Gilead Sciences, Inc. +1 4 Johnson & Johnson -3 5 Takeda -3 6 Baxter +1 7 Merck & Co. +9 8 Novo Nordisk -5 9 Bristol-Myers Squibb +10 10 Celgene -2

For a more in-depth look at this year's Pharmaceutical Innovation Index, details of the methodology and the top 30 companies, and to download the White Paper, please visit PII live on our website. For questions and comments please contact pii@ideapharma.com.

About IDEA Pharma:

Through knowledge, insight and uncommon creativity, we unlock the potential of every molecule, inspiring and empowering the pharma industry to deliver medicines that make a difference. We work with clients early in the lifecycle at proof of concept, crafting a compelling product story and building a world-class strategy that helps every molecule reach its potential. It's what we do best. And there's nobody that does it quite like us.

For further information, please visit our website or join us on Facebook, LinkedIn, and Twitter.

Past Accomplishments Include:

Path to Market Design for 7 of the top 10 (projected) oncology products by 2020 // Positioned 3 of 11 products Reuters called 2015 Blockbusters, including the Top 2 // Path to Market Design for 5 NMEs that were FDA approved in 2015

For further information please contact:

Jess Spataro 

Manager, Marketing, Brand & Communications 
IDEA Pharma 
Tel: +1-212-929-7953
Email: jess.spataro@ideapharma.com

Mike Rea 

CEO 
IDEA Pharma 
Tel: +44(0)1234-756-340
Mobile: +44-77-88-44-2839 (UK)/ +1-707-934-7509 (US)
Email: mike.rea@ideapharma.com



'/>"/>
SOURCE IDEA Pharma
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. AstraZeneca Neuroscience partners with ePharmaSolutions to optimize Clinical Trial Management
2. Innovation Rolls Out New PharmASSIST Dispenser Model 4 with Medication Self Calibration Capability
3. Virtify Announces Second Webinar on Regulatory Information Management Strategies for Small and Mid-Sized Pharmas
4. Physicians to Pharmas: Provide Patient Services or Face Irrelevance
5. ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform
6. Pharmas Are Leaving Healthcare Professionals Hanging in a Mature Mobile Market, Manhattan Research Study Finds
7. CMS Open Payments (Sunshine Act) Data Now Available on PharmaShine
8. New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine
9. PharmaSphere: North American Market Access Strategy
10. RAD Technology Medical Systems Delivers Innovative Time Saving Modular Construction At New Swedish Cancer Institute Facility
11. TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
Breaking Medicine News(10 mins):